224 Results (Page 3 of 9)
Australia Markets Research Reports
Australia Fibrodysplasia Ossificans Progressiva (FOP) Therapeutics Market Analysis
Australia Fibrodysplasia Ossificans Progressiva Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. An estimated 1.36 per Mn persons are believed to have the ultra-rare condition fibrodysplasia osseous progressiva, which affects about 900 people worldwide. The market for Fibrodysplasia Ossificans Progressiva Drugs is expanding as a result of growing incidence and prevalence of fibrodysplasia ossificans progressiva, increase in the number of R&D activities, increase in Partnerships and Collaborations between market players. Pfizer Inc., AstraZeneca, Limited, Regeneron Pharmaceuticals, Inc, Clementia Pharmaceuticals, Novartis are the top key market players operating in the global Fibrodysplasia Ossificans Progressiva Therapeutics Market.
Australia Duchenne Muscular Dystrophy (DMD) Drugs Market Analysis
Australia Cystic Fibrosis Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Duchenne Muscular Dystrophy (DMD) Drugs is expanding as a result of rising incidence and prevalence of duchenne muscular dystrophy, improved diagnosis of the disease, emergence of mutation specific and gene specific therapies, favourable government initiatives and supportive regulatory environments in various countries. Sarepta therapeutics, PTC therapeutics, Santhera pharmaceuticals are the top key market players operating in the Cystic fibrosis drugs market.
Australia Pyruvate Kinase (PK) Deficiency Market Analysis
Australia Pyruvate Kinase (PK) deficiency market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Pyruvate Kinase (PK) deficiency is growing rapidly as a result of increase in incidence and prevalence of disease, increased awareness about the disease, improved diagnostic techniques, advancements in treatment options, increase in research and development and rise in patient assistance programmes. Agios pharmaceuticals, Pfizer Inc., Sanofi, Novartis, Teva Pharmaceutical Industries Ltd, Green cross corporation are the top key market players operating in the global Pyruvate Kinase (PK) deficiency market.
Australia Virtual Clinical Trials Market Analysis
This report presents a strategic analysis of the Australia Virtual Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Australia Virtual Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Australia ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
The Australia ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $355 Mn in 2022 to $553 Mn by 2030, registering a CAGR of 5.70% during the forecast period of 2022 - 2030. The drivers for the ADHD drugs market in Australia include the increasing diagnosis and awareness of ADHD, the availability of effective treatment options, and government funding for ADHD medications. Some of the well known brands of ADHD drugs are Ritalin, Concerta, Adderall, Vyvanse, Strattera and Dexamphetamine.
Australia Robotic Surgery Services Market Analysis
The Australia Robotic Surgery Service market size was valued at $51 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 20.8% % from 2022 to 2030 and will reach $233 Mn in 2030. The robotic surgery service market will grow due to the rising patient population and increased use of sophisticated automated surgical tools. The market is segmented by product and service type, application type, and end user. Some of the major players are Sirtex Medical, Medical Robotics Technologies, Flinders Medical Centre, St Vincent's Hospital and others
Australia Growth Hormone Deficiency Clinical Trials Market Analysis
This report presents a strategic analysis of the Australia Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Australia Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Australia Healthcare Diagnostics Market Analysis
Australia's healthcare diagnostic market is valued at $xx Bn in 2022 and would likely grow at a CAGR of 1.5% during 2022-2030. The Australia healthcare diagnostic market is segmented by product, end-user, and test type. The factors affecting its growth are prevalent chronic diseases, the rising geriatric population, insurance and reimbursement, and regulating bodies. Some key market players in healthcare diagnostics in Australia are Am Diagnostics, Ramsay Health Care, and Consultant Pathology Services Pty. Limited.
Australia Diagnostic Imaging Services Market Analysis
Australia's Diagnostic Imaging Services market size was valued at $6.3 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030 and will reach $10.3 Bn in 2030. The market is segmented by product, application, and end user. The Australia Diagnostic Imaging Services market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait times and delays in diagnosis and treatment. The key market players are Sonic Healthcare Limited (AUS), I-MED Radiology Network (AUS), Capitol Health Limited (AUS), Integral Diagnostics Limited (AUS), and others.
Australia Lysosomal Storage Disorders Drugs Market Analysis
Australia Lysosomal Storage Disease Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The rise in lysosomal diseases, greater public awareness of unusual lysosomal storage disorders, increased research and development for diagnostics, and increased drug development for treating lysosomal diseases are the main drivers impacting the market for lysosomal storage disease treatments. Major global players in Lysosomal Storage Disease Drugs Market are Pfizer Inc, Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi (Genzyme Corporation), BioMarin, Johnson & Johnson (Actelion Pharmaceuticals Ltd), Amicus Drugs, Inc, Alexion Pharmaceuticals, Inc, Sigilon Drugs, Inc, and Orphazyme A/S are some of the companies that participate in this industry.
Australia Leukocyte Adhesion Deficiency (LAD-I) Market Analysis
Australia Leukocyte Adhesion Deficiency (LAD-I) therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. An uncommon genetic condition called leukocyte adhesion deficiency (LAD-I) impairs the immune system's capacity to combat infections. There is currently no cure for LAD-I, and there are few effective treatments available. To fill this unmet medical need, new medicines are becoming more and more popular. Vertex Pharmaceuticals, Orpha Labs, Avalo Therapeutics, Inc., Rocket Pharmaceuticals, Inc., Aspen Neuroscience, Magenta Therapeutics, Rubius Therapeutics, Enochian Biosciences, Sana Biotechnology, and Sigma-Aldrich are major global players.
Australia Over The Counter (OTC) Analgesics Market Analysis
This report presents a strategic analysis of the Australian over-the-counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Australian over-the-counter (OTC) Analgesics Market, offering unmatched value, accuracy, and expert insights.
Australia Electronic Records Management Solutions Market Analysis
Australia's electronic records management solutions market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by solution and deployment. Australia's electronic records management solutions market is growing as there is a rising need for effective digital data management in businesses across various sectors, including healthcare, government, and financial services. The key market players are Objective Corporation (AUS), RecordPoint (AUS), ELO Digital Office Australia (AUS), DocuWare Australia (AUS), OpenText (AUS), and others.
Australia Cancer Pain Management Market Analysis
Australia's Cancer Pain Management market is projected to grow from $78.24 Mn in 2022 to $132.43 Mn by 2030, registering a CAGR of 6.8% during the forecast period of 2022-2030. The main factors driving the growth would be as growing private healthcare sector, aging population, government initiatives, and increasing cancer incidence. The market is segmented by drug type and by disease. Some of the major players include Little Green Pharma (AUS), Phebra (AUS), Pfizer, Teva Pharmaceuticals, and Sanofi
Australia Women Health Diagnostic Market Analysis
This report presents a strategic analysis of the Australia Women's Health Diagnostic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Australian Women's Health Diagnostic Market, offering unmatched value, accuracy, and expert insights.
Australia Medical and Diagnostic Laboratory Service Market Analysis
This report presents a strategic analysis of the Australia Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Australia Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy and expert insights.
Australia Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Australia Lung Cancer Therapeutics Market will reach a value of $745 Mn from $358 Mn in 2022, growing at a CAGR of 9.6% during 2022-2030. The Lung Cancer Therapeutics Market in Australia is dominated by a few domestic pharmaceutical companies such as CSL Behring, Sirtex Medical, and Imugene. The Lung Cancer Therapeutics Market in Australia is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Australian lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Australia Breast Cancer Therapeutics Market Analysis
Increased incidence of breast cancer and the emergence of novel technologies for breast cancer treatments have propelled the Australian breast cancer therapeutics market from $218 Mn in 2022 to $641 Mn in 2030 with a CAGR of 14.4% for the year 2022-2030. The breast cancer therapeutics market is segmented by therapy, by cancer type, and by distribution channel. Novartis, GlaxoSmithKline Plc, and Kyowa Kirin Co. Ltd are leading players in the Australian breast cancer therapeutics market.
Australia Cardiovascular Drugs Market Analysis
Australia Cardiovascular Drug Market is at around $1.67 Bn in 2022 and is projected to reach $2.51 Bn in 2030, exhibiting a CAGR of 5.3% during the forecast period. The customized medicine, digital health integration, and changing environment of the Australian cardiovascular drug industry all point to great potential for long-term growth in the sector. The market is dominated by key players like Bristol-Myers Squibb Co, Pfizer, Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca Inc., Sanofi-Aventis Inc., Novartis Pharmaceuticals, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.
Australia Nutritional Supplements Market Analysis
By 2030, it is anticipated that the Australian nutritional and supplements market will reach a value of $9.81 Bn from $4.58 Bn in 2022, growing at a CAGR of 10% during 2022-30. The market is primarily dominated by local players such as Blackmores, BioMedicals, Nutralife, and Life-Space. The market for nutrition and supplements in Australia is primarily driven by reimbursement scenarios, increasing customer awareness, and increasing disposable incomes. The Australian nutrition and supplements market in Australia is segmented by Type, Product, application, and Distribution Channel.
Australia Sleep Disorders Market Analysis
This report presents a strategic analysis of the Australia Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Australia Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
Australia Retail Pharmacy Market Analysis
Australia's Retail Pharmacy Market is projected to grow from $12.46 Bn in 2022 to $23.76 Bn by 2030, registering a CAGR of 8.4% during the forecast period of 2022-30. It is anticipated that the Prescription Drugs segment will continue to hold the largest share during the forecast period. Chemist Warehouse is one of the largest retail pharmacy chains in Australia, with over 400 stores across the country. It is known for offering a wide range of products at competitive prices.
Australia Radiotherapy Market Analysis
By 2030, it is anticipated that the Australia Radiotherapy Market will reach a value of $148 Mn from $83 Mn in 2022, growing at a CAGR of 7.5% during 2022-2030. The Radiotherapy Therapeutics Market in Australia is dominated by a few domestic players such as Vision RT, Australian Radiotherapy, and GenesisCare. The radiotherapy market in Australia is segmented into different types, technologies, procedures, applications, and end-users. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Australian radiotherapy is increasing due to the rise in cancer cases in the country.
Australia Patient Engagement Solutions Market Analysis
Australia's patient engagement solutions market is projected to grow from $204.12 Mn in 2022 to $570.12 Mn by 2030, registering a CAGR of 13.7% during the forecast period of 2022-30. The main factors driving the growth would be advancements in digital health, increasing healthcare spending, the growing prevalence of chronic diseases, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and end-user. Some of the major players include HotDoc, HealthEngine, MedAdvisor, Allscripts, Cerner, and Mckesson.
Australia Palliative Care Market Analysis
Australia's palliative care market is projected to grow from $156.96 Mn in 2022 to $324.42 Mn by 2030, registering a CAGR of 9.5% during the forecast period of 2022–30. The main factors driving the growth would be as increasing prevalence of chronic diseases, the growing aging population, advancements in technology, and government support. The market is segmented by service type and by the end user. Some of the major players include Hammond Care, Japara Healthcare, Aveo Group, Brightwater Care Group, and Home Instead.